About the Authors
- Jose I. Bernardino
-
Roles Conceptualization, Investigation, Writing – original draft, Writing – review & editing
* E-mail: jose.bernardino@salud.madrid.org
Affiliation Department of Internal Medicine, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
- Amanda Mocroft
-
Roles Formal analysis, Methodology, Writing – review & editing
Affiliation University College London, London, United Kingdom
- Cedrick Wallet
-
Roles Data curation, Methodology, Project administration, Writing – review & editing
Affiliation University of Bordeaux INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France
- Stéphane de Wit
-
Roles Conceptualization, Investigation, Writing – review & editing
Affiliation CHU Saint Pierre, Université Libre de Bruxeles, Brussels, Belgium
- Christine Katlama
-
Roles Conceptualization, Investigation, Writing – review & editing
Affiliation Hôpital Pitié Salpétrière, Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France
- Peter Reiss
-
Roles Conceptualization, Investigation, Writing – review & editing
Affiliation Department of Global Health and Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Patrick W. Mallon
-
Roles Conceptualization, Investigation, Writing – review & editing
Affiliation School of Medicine, University College Dublin, Dublin, Ireland
- Laura Richert
-
Roles Methodology, Writing – review & editing
Affiliation University of Bordeaux INSERM, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France
- Jean-Michel Molina
-
Roles Investigation, Writing – review & editing
Affiliation Hôpital Saint-Louis, University of Paris Diderot, Paris, INSERM U941, France
- Hernando Knobel
-
Roles Investigation, Writing – review & editing
Affiliation Department of Infectious Diseases, Hospital del Mar, Universidad Autónoma de Barcelona, Spain
- Philippe Morlat
-
Roles Investigation, Writing – review & editing
Affiliation Service de Medicine Interne et Maladies Infectieuses, CHU Bordeaux, Université de Bordeaux, Inserm U 1219, Bourdeaux, France
- Abdel Babiker
-
Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing
Affiliation MRC Clinical Trials Unit at UCL, London, United Kingdom
- Anton Pozniac
-
Roles Investigation, Writing – review & editing
Affiliation Chelsea and Westminster hospital NHS Foundation Trust, London, United Kingdom
- Francois Raffi
-
Roles Conceptualization, Investigation, Writing – review & editing
Affiliation Department of infectious diseases, CHU de Nantes and CIC 1413, INSERM, Nantes, France
- Jose R. Arribas
-
Roles Conceptualization, Investigation, Writing – review & editing
Affiliation Department of Internal Medicine, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain
- the NEAT001/ANRS143 Trial Study Group
-
¶Membership of the NEAT001/ANRS143 Trial Study Group is provided in the Acknowledgments
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: JIB reports grants from Ministerio de Sanidad, Servicio Sociales e Iguadad (TRA-054), during the conduct of the study; personal fees from Gilead Sciences, ViiV Healthcare, MSD, and Janssen. JRA reports grants and personal fees from Gilead, personal fees from Janssen, ViiV and Merck. CW reports grants from European Commission and Inserm-ANRS, non-financial support from Gilead, Janssen Pharmaceuticals and Merck during the conduct of the study; grants from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen Pharmaceuticals, MSD, Pfizer, Roche, Tibotec, and ViiV Healthcare to the author's institution outside the submitted work. LR reports grants from European Commission and Inserm-ANRS, non-financial support from Gilead, Janssen Pharmaceuticals and Merck during the conduct of the study; grants from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen Pharmaceuticals, MSD, Pfizer, Roche, Tibotec, and ViiV Healthcare to the author's institution, outside the submitted work. AB reports grants from EU Fifth Framework Programme (though NEAT network of excellence), grants from ANRS, France, grants from Medical Research Council, UK, during the conduct of the study. AM reports personal fees from ViiV, Pfizer, BI, Gilead, Merck, BMS and Wragge LLC, outside the submitted work. JMM reports grants from Merck and Gilead, personal fees from Merck, Gilead,BMS, ViiV, TEVA, and Janssen outside the submitted work. CK reports having received consultancy fees and/or travel grants from Merck, Gilead, BMS, ViiV, BMS, and Janssen. PWM reports grants and personal fees from Gilead Sciences, ViiV Healthcare, Janssen Cilag, and MSD outside the submitted work. PM reports personal fees from Gilead and MSD Board, personal fees from ViiV health care consultancy, outside the submitted work. PR reports grants from Gilead, ViiV Healthcare, Janssen Pharmaceutica, Bristol Myers Squibb, and Merck & Co. FR received research funding or honoraria from or consulted for Gilead Sciences, Janssen Pharmaceuticals, MSD, and Merck. AP reports grants from SSAT, and NEAT, during the conduct of the study; personal fees from Janssen, Gilead, Merck, outside the submitted work; and was vice chair of NEAT and was on BHIVA and EACS ART guidelines committees at time of study. All other authors declare no conflicts of interest. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.